<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02919332</url>
  </required_header>
  <id_info>
    <org_study_id>16-000600</org_study_id>
    <secondary_id>NCI-2016-01214</secondary_id>
    <secondary_id>16-000600 JCCCID655</secondary_id>
    <secondary_id>16-000600</secondary_id>
    <secondary_id>P30CA016042</secondary_id>
    <nct_id>NCT02919332</nct_id>
  </id_info>
  <brief_title>Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma</brief_title>
  <official_title>Improved Visualization of Glioblastoma Using Delayed 18F-FDG PET/CT.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jonsson Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Jonsson Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial studies how well delayed fludeoxyglucose F-18 (18F-FDG) positron emission
      tomography (PET)/computed tomography (CT) works in improving visualization of brain tumors in
      patients with glioblastoma. Radiotracers such as 18F-FDG are highly taken up by tumors in the
      brain and are visualized using PET/CT. Increasing the interval of time between 18F-FDG
      administration and PET/CT scan may improve the visualization of brain tumors in patients with
      glioblastoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. To improve the visualization/delineation of glioblastoma lesions using delayed 18F-FDG
      PET/CT imaging.

      OUTLINE:

      Patients receive fludeoxyglucose F-18 intravenously (IV). Patients then undergo a standard of
      care PET/CT scan at 60 minutes and a second PET/CT scan at 240 minutes after injection.

      Note:

      Standard Uptake Value (SUV) is defined for state-of-the art PET/CT scanners as Standardized
      uptake values = count activity per ml within region of interest (MBq/ml)/[injected dose
      (MBq)/body weight (kgx1000)]
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 8, 2016</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tumor-to-background ratio on delayed scans (240 min after injection)</measure>
    <time_frame>Baseline up to 240 minutes after injection</time_frame>
    <description>Ratio between Standardized uptake values (tumor region) and Standardized uptake values (physiological uptake of brain tissue)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tumor-to-background ratio on standard scans (60 min after injection)</measure>
    <time_frame>Baseline up to 60 minutes after injection</time_frame>
    <description>Ratio between Standardized uptake values (tumor region) and Standardized uptake values (physiological uptake of brain tissue)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Standard uptake value comparison</measure>
    <time_frame>240 minutes post injection</time_frame>
    <description>Comparison of Standardized uptake values (tumor region) to visual and quantitative parameters on delayed scans (240 min after injection)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Standard uptake value comparison</measure>
    <time_frame>60 minutes post injection</time_frame>
    <description>Comparison of Standardized uptake values (tumor region) to visual and quantitative parameters on standard scans (60 min after injection)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Glioblastoma</condition>
  <condition>Glioma</condition>
  <arm_group>
    <arm_group_label>Diagnostic (18F-FDG PET/CT)</arm_group_label>
    <description>Patients receive fludeoxyglucose F-18 IV. Patients then undergo a standard of care PET/CT scan at 60 minutes and a second PET/CT scan at 240 minutes after injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Computed Tomography</intervention_name>
    <description>Undergo 18F-FDG PET/CT</description>
    <arm_group_label>Diagnostic (18F-FDG PET/CT)</arm_group_label>
    <other_name>CAT</other_name>
    <other_name>CAT Scan</other_name>
    <other_name>Computerized Axial Tomography</other_name>
    <other_name>Computerized Tomography</other_name>
    <other_name>CT</other_name>
    <other_name>CT SCAN</other_name>
    <other_name>tomography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Fludeoxyglucose F-18</intervention_name>
    <description>Given IV</description>
    <arm_group_label>Diagnostic (18F-FDG PET/CT)</arm_group_label>
    <other_name>18FDG</other_name>
    <other_name>FDG</other_name>
    <other_name>fludeoxyglucose F 18</other_name>
    <other_name>Fludeoxyglucose F18</other_name>
    <other_name>Fluorine-18 2-Fluoro-2-deoxy-D-Glucose</other_name>
    <other_name>Fluorodeoxyglucose F18</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Positron Emission Tomography</intervention_name>
    <description>Undergo 18F-FDG PET/CT</description>
    <arm_group_label>Diagnostic (18F-FDG PET/CT)</arm_group_label>
    <other_name>Medical Imaging, Positron Emission Tomography</other_name>
    <other_name>PET</other_name>
    <other_name>PET SCAN</other_name>
    <other_name>Positron Emission Tomography Scan</other_name>
    <other_name>Positron-Emission Tomography</other_name>
    <other_name>proton magnetic resonance spectroscopic imaging</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients older than 18 years of age who have been diagnosed with a brain tumor and are
        undergoing a PET/CT scan..
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with histologically proven high grade glioma scheduled for 18F-FDG PET/CT

        Exclusion Criteria:

          -  Severe psychiatric illness

          -  Inability to give written consent

          -  Breast feeding/pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johannes Czernin</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCLA / Jonsson Comprehensive Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCLA / Jonsson Comprehensive Cancer Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Czernin</last_name>
      <phone>310-794-1005</phone>
    </contact>
    <investigator>
      <last_name>Johannes Czernin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2016</study_first_submitted>
  <study_first_submitted_qc>September 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2016</study_first_posted>
  <last_update_submitted>October 11, 2017</last_update_submitted>
  <last_update_submitted_qc>October 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioblastoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

